Vice President, Research

About Cancercare Manitoba

Cancer Care Manitoba (CCMB) is the provincial cancer authority responsible for setting strategic priorities and long-term planning for cancer and blood disorders. CCMB provides prevention, early detection, multidisciplinary treatment, and supportive to end-of-life care for both children and adults. The organization also oversees radiation protection across Manitoba. Through the Paul Albrechtsen Research Institute Cancer Care Manitoba, CCMB conducts research on all aspects of cancer and blood disorders, including studies aimed at improving patient care and experience.

Cancer Care Manitoba relies on the ongoing support of Manitoba Health, Seniors and Long-Term Care and its close working relationships with regional health authorities to deliver quality cancer services to Manitobans. The financial assistance provided by the donations of Manitobans to the Cancer Care Manitoba Foundation is vital to undertaking research and providing quality care to Manitobans.

The organization’s multidisciplinary approach to patient care attracts experts in medical, radiation, and surgical oncology, hematology, the best and brightest scientists, passionate nursing staff, and other dedicated healthcare professionals.

CCMB operates five sites in Winnipeg, with the main location at 675 McDermot Avenue offering systemic and radiation therapy, patient support services, and housing the Research Institute. In partnership with Prairie Mountain Health, the Western Manitoba Cancer Centre in Brandon provides radiation and systemic therapy, along with patient support services for residents of western Manitoba.

Five locations in Winnipeg and one location in Brandon | 1100+ team members | $340 million operating budget

Leading the way in cancer control

Reduce the risk and impact of cancer for all people of Manitoba through world class cancer control, research, and education

Dignity, fairness, openness, equity, collaboration, co- operation, sensitivity to cultural diversity and identity, compassion

Honesty, objectivity, reliability, responsibility, fidelity, transparency

Prudence, sensitivity to risks, opportunities and sustainability of human and material resources and the natural and built environment, accountability

Timeliness, efficiency, effectiveness, relevance, diligence, creativity, initiative

The Paul Albrechtsen Research Institute Cancer Care Manitoba (the 'Institute') is embedded within CCMB and is dedicated to advancing research and innovation across cancer and blood disorders. Its work is closely connected to Manitoba’s cancer system and is informed by the real-world questions faced by patients, families, clinicians, and researchers.

The Institute builds on a long research history that began in 1969 through the Manitoba Institute of Cell Biology, a joint initiative with the University of Manitoba. It has evolved into a multidisciplinary research institute encompassing basic science, preclinical and translational research, clinical trials, health services research, health care informatics, epidemiology, and psychosocial oncology research.

Today, the Institute brings together clinicians, scientists, technicians, research nurses, trainees, bioinformaticians, and other specialized professionals to translate discoveries into better patient and population outcomes. It is supported through a long-standing partnership with the Cancer Care Manitoba Foundation, which funds operational support, research platforms, equipment, education, and training.

In May 2023, the Institute was renamed to recognize a transformative $27 million gift from the Paul Albrechtsen Foundation. This generous gift has allowed CCMB to undertake a major renovation of the research labs currently underway and is expected to be completed in December 2027. The Institute’s platforms and resources include areas such as the Manitoba Tumour Bank, the Manitoba Cancer Registry, genomics and bioinformatics, cancer modelling and imaging, clinical informatics, and quantitative imaging, phenotyping and sorting.

The Institute organizes its scientific investigation, staffing, resources and investment across three interrelated research disciplines. Together, these disciplines span the full breadth of cancer and blood disorder research, with the patient at the center of every effort.

Understanding how cancer and blood disorders work at a fundamental level and translating those discoveries into new approaches to prevent, detect and treat disease.

Advancing new and better ways to prevent, find and treat cancer through clinical trials and investigator-initiated studies, including areas such as hematology, radiation oncology and patient experience.

Examining the structure, processes and effects of health care services and systems - including…